Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab

INTRODUCTION: Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated with a poorer response to Infliximab. H...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Scaldaferri, Franco, D‘Ambrosio, Daria, Holleran, Grainne, Poscia, Andrea, Petito, Valentina, Lopetuso, Loris, Graziani, Cristina, Laterza, Lucrezia, Pistone, Maria Teresa, Pecere, Silvia, Currò, Diego, Gaetani, Eleonora, Armuzzi, Alessandro, Papa, Alfredo, Cammarota, Giovanni, Gasbarrini, Antonio
Format: Artigo
Language:Inglês
Published: Public Library of Science 2017
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657978/
https://ncbi.nlm.nih.gov/pubmed/29073159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0186575
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items